Physician profile
Patrick William Nelson
NPI 1952719817
$769.90
in general payments reported to CMS, 2019-2025
13 companies · $53.67 in 2025
The $53.67 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.91 · 2021: $123 · 2022: $373 · 2023: $153 · 2024: $56.50 · 2025: $53.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $147.63 | 2022 | |
| Rxsight INC | $130.44 | 2022 | |
| Dompe US, INC. | $122.85 | 2021 | |
| Apellis Pharmaceuticals, INC. | $106.49 | 2023 | Syfovre |
| Horizon Therapeutics Plc | $80.73 | 2022 | |
| Notal Vision, INC. | $40.00 | 2025 | Foresee Home |
| Sun Pharmaceutical Industries INC. | $32.30 | 2023-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $32.15 | 2024 | Xdemvy |
| Astellas Pharma US INC | $24.35 | 2024 | Izervay |
| Coopervision INC. | $14.52 | 2023 | Myday Contact Lens |
| Bausch & Lomb Americas INC. | $14.21 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $13.32 | 2023 | Acuvue |
| Novartis Pharmaceuticals Corporation | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.